Pfizer Inc. (PFE) - צמיחת רווחי EPS רבעונית
Pfizer Inc. possesses colossal authority in medicine due to the creation of life-saving vaccines. This reputation supports revenue stability, although reliance on patents forces the company to acquire startups. This quarterly EPS chart clearly confirms these processes, where the parameter value reaches -8.90. Currently, management under Albert Bourla is optimizing expenses to restore investor confidence in the post-pandemic period.
%20%D7%A9%D7%99%D7%A0%D7%95%D7%99%20%D7%91%D7%A8%D7%95%D7%95%D7%97%20%D7%A0%D7%A7%D7%99%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94%20%D7%9E%D7%A9%D7%A0%D7%94%20%D7%9C%D7%A9%D7%A0%D7%94%20%D7%91%D7%A9%D7%A0%D7%99%D7%9D%20%D7%A2%D7%A9%D7%A8%20%D7%94%D7%97%D7%95%D7%93%D7%A9%D7%99%D7%9D%20%D7%94%D7%90%D7%97%D7%A8%D7%95%D7%A0%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_PFE_-_Pfizer-Inc._-_Year-over-year-net-earnings-per-share-change-for-the-last-twelve-months "PFE Pfizer Inc: צמיחת רווח למניה משנה לשנה בשנים עשר החודשים האחרונים בטווח 04.07.2022 - 10.11.2026 | 👁️GURU.Markets👁️")
פילוחים אנליטיים של חברת Pfizer Corp (PFE)
This indicator measures the quarterly change in earnings per share, reflecting the business's capitalization rate. The effective combination of in-house substance synthesis and outsourced clinical trials directly impacts this calculation. By analyzing the quarterly shift in earnings per share, an investor can see the actual speed of value generation. Growth in this metric confirms the resilience of the Pfizer Inc. (PFE) operating model, serving as a signal regarding the quality of capital allocation.
